Medicinal Organometallic Chemistry keeps contributing to drug discovery efforts including the development of diagnostic compounds. Despite the limiting issues of metal-based molecules, e.g., such as toxicity, there are drugs approved for clinical use and several others are under clinical and pre-clinical development. Indeed, several research groups continue working on organometallic compounds with potential therapeutic applications. For arguably historical reasons, chemoinformatic methods in drug discovery have been applied thus far mostly to organic compounds. Typically, metal-based molecules are excluded from compound data sets for analysis. Indeed, most software and algorithms for drug discovery applications are focused and parametrized for organic molecules. However, considering the emerging field of material informatics, the objective of this Commentary we emphasize the need to develop cheminformatic applications to further develop metallodrugs. For instance, one of the starting points would be developing a compound database of organometallic molecules annotated with biological activity. It is concluded that chemoinformatic methods can boost the research area of Medicinal Organometallic Chemistry.
References
[1]
Mjos, K.D. and Orvig, C. (2014) Metallodrugs in Medicinal Inorganic Chemistry. Chemical Reviews, 114, 4540-4563. https://doi.org/10.1021/cr400460s
[2]
Markwalter, C.F., Kantor, A.G., Moore, C.P., Richardson, K.A. and Wright, D.W. (2019) Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics. Chemical Reviews, 119, 1456-1518. https://doi.org/10.1021/acs.chemrev.8b00136
[3]
Wang, Y., Li, H. and Sun, H. (2019) Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs. Inorganic Chemistry, 58, 13673-13685. https://doi.org/10.1021/acs.inorgchem.9b01199
[4]
Kenny, R.G. and Marmion, C.J. (2019) Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens? Chemical Reviews, 119, 1058-1137. https://doi.org/10.1021/acs.chemrev.8b00271
[5]
Medina-Franco, J.L., Martinez-Mayorga, K. and Meurice, N. (2014) Balancing Novelty with Confined Chemical Space in Modern Drug Discovery. Expert Opinion on Drug Discovery, 9, 151-165. https://doi.org/10.1517/17460441.2014.872624
[6]
Méndez-Lucio, O. and Medina-Franco, J.L. (2017) The Many Roles of Molecular Complexity in Drug Discovery. Drug Discovery Today, 22, 120-126. https://doi.org/10.1016/j.drudis.2016.08.009
[7]
Kircheva, N. and Dudev, T. (2019) Novel Insights into Gallium’s Mechanism of Therapeutic Action: A DFT/PCM Study of the Interaction between Ga3+ and Ribonucleotide Reductase Substrates. The Journal of Physical Chemistry B, 123, 5444-5451. https://doi.org/10.1021/acs.jpcb.9b03145
[8]
Sciortino, G., Garribba, E. and Maréchal, J.-D. (2019) Validation and Applications of Protein-Ligand Docking Approaches Improved for Metalloligands with Multiple Vacant Sites. Inorganic Chemistry, 58, 294-306. https://doi.org/10.1021/acs.inorgchem.8b02374
[9]
Duffy, B.C., Zhu, L., Decornez, H. and Kitchen, D.B. (2012) Early Phase Drug Discovery: Cheminformatics and Computational Techniques in Identifying Lead Series. Bioorganic & Medicinal Chemistry, 20, 5324-5342. https://doi.org/10.1016/j.bmc.2012.04.062
[10]
Miller, M.A. (2002) Chemical Database Techniques in Drug Discovery. Nature Reviews Drug Discovery, 1, 220-227. https://doi.org/10.1038/nrd745
[11]
Walters, W.P. (2019) Virtual Chemical Libraries. Journal of Medicinal Chemistry, 62, 1116-1124. https://doi.org/10.1021/acs.jmedchem.8b01048
[12]
Yang, J.F., Wang, D., Jia, C.Y., Wang, M.Y., Hao, G.F. and Yang, G.F. (2019) Freely Accessible Chemical Database Resources of Compounds for in Silico Drug Discovery. Current Medicinal Chemistry, 26, 7581-7597. https://doi.org/10.2174/0929867325666180508100436
[13]
Percastre-Cruz, Y. and Medina-Franco, J.L. (2019) Towards a Compound Database of Organometallic Drugs for Chemoinformatic Simulations. 3rd International Conference in Bioinformatics, Simulations and Modeling (iCBSM), Talca, Chile, 4-8 November 2019.
[14]
Yoshimori, A., Tanoue, T. and Bajorath, J. (2019) Integrating the Structure-Activity Relationship Matrix Method with Molecular Grid Maps and Activity Landscape Models for Medicinal Chemistry Applications. ACS Omega, 4, 7061-7069. https://doi.org/10.1021/acsomega.9b00595
[15]
Bender, A. (2010) Databases Compound Bioactivities Go Public. Nature Chemical Biology, 6, 309-309. https://doi.org/10.1038/nchembio.354
[16]
Maggiora, G., Vogt, M., Stumpfe, D. and Bajorath, J. (2014) Molecular Similarity in Medicinal Chemistry. Journal of Medicinal Chemistry, 57, 3186-3204. https://doi.org/10.1021/jm401411z
[17]
Sciortino, G., Garribba, E., Pedregal, J.R.-G. and Maréchal, J.-D. (2019) Simple Coordination Geometry Descriptors Allow to Accurately Predict Metal-Binding Sites in Proteins. ACS Omega, 4, 3726-3731. https://doi.org/10.1021/acsomega.8b03457
[18]
Medina-Franco, J.L. (2012) Interrogating Novel Areas of Chemical Space for Drug Discovery Using Chemoinformatics. Drug Development Research, 73, 430-438. https://doi.org/10.1002/ddr.21034
[19]
Lenci, E., Menchi, G., Saldívar-Gonzalez, F.I., Medina-Franco, J.L. and Trabocchi, A. (2019) Bicyclic Acetals: Biological Relevance, Scaffold Analysis, and Applications in Diversity-Oriented Synthesis. Organic & Biomolecular Chemistry, 17, 1037-1052. https://doi.org/10.1039/C8OB02808G
[20]
López-Vallejo, F., Nefzi, A., Bender, A., Owen, J.R., Nabney, I.T., et al. (2011) Increased Diversity of Libraries from Libraries: Chemoinformatic Analysis of Bis-Diazacyclic Libraries. Chemical Biology & Drug Design, 77, 328-342. https://doi.org/10.1111/j.1747-0285.2011.01100.x
[21]
Medina-Franco, J.L., Naveja, J.J. and López-López, E. (2019) Reaching for the Bright Stars in Chemical Space. Drug Discovery Today, 24, 2162-2169. https://doi.org/10.1016/j.drudis.2019.09.013
[22]
Virshup, A.M., Contreras-García, J., Wipf, P., Yang, W. and Beratan, D.N. (2013) Stochastic Voyages into Uncharted Chemical Space Produce a Representative Library of All Possible Drug-Like Compounds. Journal of the American Chemical Society, 135, 7296-7303. https://doi.org/10.1021/ja401184g
[23]
Naveja, J. and Medina-Franco, J. (2017) Chemmaps: Towards an Approach for Visualizing the Chemical Space Based on Adaptive Satellite Compounds. F1000Research, 6, 1134. https://doi.org/10.12688/f1000research.12095.1
[24]
Saldívar-González, F.I., Valli, M., Andricopulo, A.D., da Silva Bolzani, V. and Medina-Franco, J.L. (2019) Chemical Space and Diversity of the Nubbe Database: A Chemoinformatic Characterization. Journal of Chemical Information and Modeling, 59, 74-85. https://doi.org/10.1021/acs.jcim.8b00619
[25]
Olmedo, D.A., González-Medina, M., Gupta, M.P. and Medina-Franco, J.L. (2017) Cheminformatic Characterization of Natural Products from Panama. Molecular Diversity, 21, 779-789. https://doi.org/10.1007/s11030-017-9781-4
[26]
Lavecchia, A. (2019) Deep Learning in Drug Discovery: Opportunities, Challenges and Future Prospects. Drug Discovery Today, 24, 2017-2032. https://doi.org/10.1016/j.drudis.2019.07.006
[27]
Maggiora, G.M. (2006) On Outliers and Activity Cliffs—Why QSAR Often Disappoints. Journal of Chemical Information and Modeling, 46, 1535. https://doi.org/10.1021/ci060117s
[28]
Ramprasad, R., Batra, R., Pilania, G., Mannodi-Kanakkithodi, A. and Kim, C. (2017) Machine Learning in Materials Informatics: Recent Applications and Prospects. NPJ Computational Materials, 3, 54. https://doi.org/10.1038/s41524-017-0056-5
[29]
Saldívar-González, F.I., Naveja, J.J., Palomino-Hernández, O. and Medina-Franco, J.L. (2017) Getting Smart in Drug Discovery: Chemoinformatics Approaches for Mining Structure-Multiple Activity Relationships. RSC Advances, 7, 632-641. https://doi.org/10.1039/C6RA26230A
[30]
Lavecchia, A. and Di Giovanni, C. (2013) Virtual Screening Strategies in Drug Discovery: A Critical Review. Current Medicinal Chemistry, 20, 2839-2860. https://doi.org/10.2174/09298673113209990001
[31]
Prieto-Martinez, F.D. and Medina-Franco, J.L. (2018) Flavonoids as Putative Epi-Modulators: Insight into Their Binding Mode with Brd4 Bromodomains Using Molecular Docking and Dynamics. Biomolecules, 8, 61. https://doi.org/10.3390/biom8030061
[32]
Wang, Y., Liu, H., Fan, Y., Chen, X., Yang, Y., et al. (2019) In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy. Journal of Chemical Information and Modeling, 59, 3968-3980. https://doi.org/10.1021/acs.jcim.9b00300
[33]
Villoutreix, B.O., Lagorce, D., Labbé, C.M., Sperandio, O. and Miteva, M.A. (2013) One Hundred Thousand Mouse Clicks Down the Road: Selected Online Resources Supporting Drug Discovery Collected over a Decade. Drug Discovery Today, 18, 1081-1089. https://doi.org/10.1016/j.drudis.2013.06.013
[34]
Gonzalez-Medina, M., Naveja, J.J., Sanchez-Cruz, N. and Medina-Franco, J.L. (2017) Open Chemoinformatic Resources to Explore the Structure, Properties and Chemical Space of Molecules. RSC Advances, 7, 54153-54163. https://doi.org/10.1039/C7RA11831G
